A METHOD FOR TREATING A STROKE BY IMPLANTING A FIRST THERAPY DELIVERY ELEMENT IN THE CNS AND A SECOND THERAPY DELIVERY ELEMENT IN A DAMAGED TISSUE OF THE CNS TO PROMOTE NEUROGENESIS

Patent №

US 8,093,205

Granted

2012-01-10

Filed 2004

Owner

MEDTRONIC, INC.

Lab

AI components

1

planning

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

11000856

Devices and methods for treating diseases associated with loss of neuronal function are described. The methods are designed to promote proliferation, differentiation, migration, or integration of endogenous progenitor stem cells of the central nervous system (CNS). A therapy, such as an electrical signal or a stem cell enhancing agent, or a combination of therapies, is applied to a CNS region containing endogenous stem cells or a CNS region where the endogenous stem cells are predicted to migrate and eventually reside, or a combination thereof.

PlanningA61K 38/18A61K 35/545A61K 38/185A61K 38/19A61N 1/326A61N 1/36082

AI classification

Planning0.72
AI hardware0.18
Natural language0.01
Machine learning0.00
Evolutionary computation0.00
Vision0.00
Speech0.00
Knowledge representation0.00

Ownership

MEDTRONIC, INC.

assignment · 157350419

Assignors

SHAFER, LISA L.

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC